Supriya Lifescience IPO Details & Review | Kotak Securities

Supriya Lifescience IPO opens on 16th December and here is a quick preview.

Supriya Lifescience Limited is an Indian Active Pharmaceutical Ingredients (API) manufacturer and supplier and has a niche product offering of 38 APIs. The company was among the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms. 

Watch this video to find out this upcoming IPO’s issue details, the company’s last three years' financial data, its product portfolio, and more. 

IPO Highlights:
IPO Period – 16th December to 20th December 2021
IPO Issue Size – Rs. 700 crore 
Price Band - Rs. 265 - Rs. 274 per equity share 

Source: RHP

Disclaimer: bit.ly/longdisc

#SupriyaLifescience #IPO #KotakSecurities #IPOReview #IPOPreview #IPOAlert

Kotak Securities is a preferred choice of millions of customers when it comes to investment decisions. With free access to credible research, competitive pricing and high-speed trading platforms such Kotak Stock Trader mobile app and KEAT Pro X, it makes investing an effortless journey for both new investors and experienced traders. To open a FREE demat and trading account with Kotak Securities, please click here: https://www.kotaksecurities.com/

Download your Kotak Stock Trading App now: https://ksec.onelink.me/7nkM/social

Trade Free Features:
Rs. 0 brokerage on intraday trades across segments
Rs. 20 per order for carry forward F&O trades

For More Information, Click Here: https://www.kotaksecurities.com/kotak...

Follow us on:

Telegram - https://t.me/KotakSecurities
Twitter:   / kotaksecurities  
Instagram:   / kotaksecurities  
LinkedIn:   / kotak-securities  
Facebook:   / kotaksecurities